Can we maintain immunosuppression avoiding nephrotoxic agents in pancreas transplantation?

Transplant Proc. 2008 Mar;40(2):516-7. doi: 10.1016/j.transproceed.2008.01.046.

Authors

R Kandaswamy¹, T Dunn, A Humar, D E R Sutherland

Affiliation

¹ Department of Surgery, University of Minnesota, Minneapolis, Minnesota 65455, USA.

PMID: 18374118
DOI: 10.1016/j.transproceed.2008.01.046

No abstract available

MeSH terms

Adrenal Cortex Hormones / therapeutic use*
Calcineurin Inhibitors
Humans
Immunosuppression Therapy / adverse effects
Immunosuppression Therapy / methods*
Immunosuppressive Agents / adverse effects
Immunosuppressive Agents / therapeutic use*
Kidney / drug effects
Kidney / pathology
Kidney Transplantation / immunology
Mycophenolic Acid / analogs & derivatives*
Mycophenolic Acid / therapeutic use
Pancreas Transplantation / immunology*
Sirolimus / therapeutic use
Tacrolimus / adverse effects

Substances

Adrenal Cortex Hormones
Calcineurin Inhibitors
Immunosuppressive Agents
Mycophenolic Acid
Sirolimus
Tacrolimus